@inbook{ddc509f0cd41426994d14227141e016b,
title = "Generating and expanding autologous chimeric antigen receptor T cells from patients with acute myeloid leukemia",
abstract = "Adoptive transfer of genetically engineered T cells can lead to profound and durable responses in patients with hematologic malignancies, generating enormous enthusiasm among scientists, clinicians, patients, and biotechnology companies. The success of adoptive cellular immunotherapy depends upon the ability to manufacture good quality T cells. We discuss here the methodologies and reagents that are used to generate T cells for the preclinical study of chimeric antigen receptor T cell therapy for acute myeloid leukemia (AML).",
keywords = "Acute myeloid leukemia, Adoptive T cell therapy, CAR T cells, Chimeric antigen receptor, Synthetic biology, T cell expansion",
author = "Kenderian, {Saad S.} and June, {Carl H.} and Saar Gill",
note = "Funding Information: This work was partly supported by grants from the University of Pennsylvania-Novartis Alliance (Carl June/Saar Gill), Leukemia Lymphoma Society (Carl June/Saar Gill), and the Predolin foundation (Saad Kenderian). Publisher Copyright: {\textcopyright} 2017, Springer Science+Business Media LLC.",
year = "2017",
doi = "10.1007/978-1-4939-7142-8_17",
language = "English (US)",
series = "Methods in Molecular Biology",
publisher = "Humana Press Inc.",
pages = "267--276",
booktitle = "Methods in Molecular Biology",
}